Suppr超能文献

皮肤利什曼病患者血清、淋巴细胞和粒细胞中的腺苷脱氨酶活性。

Adenosine deaminase activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis.

作者信息

Erel O, Kocyigit A, Gurel M S, Bulut V, Seyrek A, Ozdemir Y

机构信息

Department of Clinical Biochemistry, Medical Faculty, Harran University, Sanliurfa, Turkey.

出版信息

Mem Inst Oswaldo Cruz. 1998 Jul-Aug;93(4):491-4. doi: 10.1590/s0074-02761998000400014.

Abstract

Adenosine deaminase (ADA) activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis were investigated and compared with control groups. Fifty patients and 50 healthy individuals were studied. The clinical diagnosis was parasitologically confirmed by culture and Giemsa stain. ADA activities were measured by colorimetric method. Serum ADA activities 37.80 +/- 11.90, 18.28 +/- 6.08 IU/L (p < 0.0001), lymphocyte specific ADA activities 14.90 +/- 7.42, 8.38 +/- 7.42 U/mg protein (p = 0.04), granulocyte specific ADA activities 1.15 +/- 0.73, 1.09 +/- 0.67 U/mg protein (p > 0.05) were found in patients and control groups, respectively. ADA activity increases in some infectious diseases were cell mediated immune mechanisms are dominant. In cutaneous leishmaniasis, lymphokine-mediated macrophage activity is the main effector mechanism. Increase in serum and lymphocyte ADA activities in patients with cutaneous leishmaniasis may be dependent on and reflects the increase in phagocytic activity of macrophages and maturation of T-lymphocytes.

摘要

对皮肤利什曼病患者血清、淋巴细胞和粒细胞中的腺苷脱氨酶(ADA)活性进行了研究,并与对照组进行了比较。研究了50例患者和50名健康个体。临床诊断通过培养和吉姆萨染色在寄生虫学上得到证实。ADA活性采用比色法测定。患者组和对照组的血清ADA活性分别为37.80±11.90、18.28±6.08 IU/L(p<0.0001),淋巴细胞特异性ADA活性分别为14.90±7.42、8.38±7.42 U/mg蛋白(p = 0.04),粒细胞特异性ADA活性分别为1.15±0.73、1.09±0.67 U/mg蛋白(p>0.05)。在一些以细胞介导免疫机制为主导的传染病中ADA活性会增加。在皮肤利什曼病中,淋巴因子介导的巨噬细胞活性是主要的效应机制。皮肤利什曼病患者血清和淋巴细胞ADA活性的增加可能依赖于并反映了巨噬细胞吞噬活性的增加和T淋巴细胞的成熟。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验